Subscribe To
5 strong buy stocks near their 52-week lows
Confused about why your stock is down in 2022 when it's a Zacks Strong Buy Stock? Tracey investigates....
February 2, 2022, 3:23 pm
5 strong buy stocks near their 52-week lows
Confused about why your stock is down in 2022 when it's a Zacks Strong Buy Stock? Tracey investigates....
February 2, 2022, 3:23 pm
Why did the market drop so much in january?
The Nasdaq fell nearly 9% last month, and it left many investors confused and scared....
February 2, 2022, 9:09 am
Why did the market drop so much in january?
The Nasdaq fell nearly 9% last month, and it left many investors confused and scared....
February 2, 2022, 9:09 am
Why did the market drop so much in january?
The Nasdaq fell nearly 9% last month, and it left many investors confused and scared....
February 2, 2022, 9:09 am
Littelfuse (lfus) q4 earnings and revenues surpass estimates
Littelfuse (LFUS) delivered earnings and revenue surprises of 8.22% and 5.78%, respectively, for the qu...
February 1, 2022, 8:04 pm
Littelfuse (lfus) q4 earnings and revenues surpass estimates
Littelfuse (LFUS) delivered earnings and revenue surprises of 8.22% and 5.78%, respectively, for the qu...
February 1, 2022, 8:04 pm
Littelfuse (lfus) q4 earnings and revenues surpass estimates
Littelfuse (LFUS) delivered earnings and revenue surprises of 8.22% and 5.78%, respectively, for the qu...
February 1, 2022, 8:04 pm
Credit suisse must face investors' currency rigging lawsuit in new york
A U.S. judge on Tuesday refused to dismiss a class-action lawsuit by investors accusing Credit Suisse G...
February 1, 2022, 5:05 pm
Credit suisse must face investors' currency rigging lawsuit in new york
A U.S. judge on Tuesday refused to dismiss a class-action lawsuit by investors accusing Credit Suisse G...
February 1, 2022, 5:05 pm
Credit suisse must face investors' currency rigging lawsuit in new york
A U.S. judge on Tuesday refused to dismiss a class-action lawsuit by investors accusing Credit Suisse G...
February 1, 2022, 5:05 pm
Mastercard (ma) ties up to infuse digitization in catalonia
Mastercard (MA) joins forces with the Government of Catalonia to work on a series of projects to gradually integrate digitization within the region's ...
February 1, 2022, 1:50 pm
Mastercard (ma) ties up to infuse digitization in catalonia
Mastercard (MA) joins forces with the Government of Catalonia to work on a series of projects to gradually integrate digitization within the region's ...
February 1, 2022, 1:50 pm
Mastercard (ma) ties up to infuse digitization in catalonia
Mastercard (MA) joins forces with the Government of Catalonia to work on a series of projects to gradually integrate digitization within the region's ...
February 1, 2022, 1:50 pm
Pepsi's rockstar to offer hemp-infused beverage
PepsiCo, Inc. (NASDAQ:PEP) is joining the beverage sector's push to expand its product options, with Coca-Cola (KO) just last week unveiling a new har...
February 1, 2022, 12:05 pm
Pepsi's rockstar to offer hemp-infused beverage
PepsiCo, Inc. (NASDAQ:PEP) is joining the beverage sector's push to expand its product options, with Coca-Cola (KO) just last week unveiling a new har...
February 1, 2022, 12:05 pm
Pepsi's rockstar to offer hemp-infused beverage
PepsiCo, Inc. (NASDAQ:PEP) is joining the beverage sector's push to expand its product options, with Coca-Cola (KO) just last week unveiling a new har...
February 1, 2022, 12:05 pm
Biogen exercises option to participate developing genentech's bispecific antibody, mosunetuzumab
Biogen Inc BIIB has exercised its option to participate in the development and commercialization of mosunetuzumab, a CD20xCD3 T-cell engaging bispe...
February 1, 2022, 10:03 am
Biogen exercises option to participate developing genentech's bispecific antibody, mosunetuzumab
Biogen Inc BIIB has exercised its option to participate in the development and commercialization of mosunetuzumab, a CD20xCD3 T-cell engaging bispe...
February 1, 2022, 10:03 am
Biogen exercises option to participate developing genentech's bispecific antibody, mosunetuzumab
Biogen Inc BIIB has exercised its option to participate in the development and commercialization of mosunetuzumab, a CD20xCD3 T-cell engaging bispe...
February 1, 2022, 10:03 am